Viewing Company
Company Name:
Purple Biotech Ltd.
CIK:
1614744
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2018-03-05
Last Filing Date:
2025-03-10
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2018-01-01 | 2018-06-30 | CY2018Q2I | 2018-09-17 | 0001213900-18-012612 | $ 248,117,119 | View |
| 2019-01-01 | 2019-06-30 | CY2019Q2I | 2019-08-26 | 0001213900-19-016695 | $ 19,183,303 | View |
| 2020-01-01 | 2020-12-31 | None | 2021-03-16 | 0001213900-21-015453 | $ 1,209,000 | View |
| 2020-01-01 | 2020-12-31 | CY2018 | 2021-03-16 | 0001213900-21-015664 | $ 1,209,000 | View |
| 2017-01-01 | 2017-12-31 | CY2015 | 2018-03-05 | 0001213900-18-002558 | $ 189,139,031 | View |
| 2018-01-01 | 2018-12-31 | CY2016 | 2019-03-26 | 0001213900-19-004878 | $ 14,205,301 | View |
| 2021-01-01 | 2021-12-31 | CY2020 | 2023-03-03 | 0001213900-23-017024 | $ 642,000 | View |
| 2023-01-01 | 2023-12-31 | CY2023 | 2024-03-05 | 0001213900-24-020111 | $ 4,600,000 | View |
| 2024-01-01 | 2024-12-31 | CY2024 | 2025-03-10 | 0001213900-25-022192 | $ 0 | View |
| 2019-01-01 | 2019-12-31 | CY2019 | 2020-03-23 | 0001213900-20-007156 | $ 894,000 | View |
| 2021-01-01 | 2021-12-31 | CY2021 | 2022-03-09 | 0001213900-22-011191 | $ 1,047,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| ifrs-full | 3444230 | None | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. | View |
| us-gaap | Other Income | Amount of revenue and income classified as other. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |